SARS-CoV-话题@MedSci

#SARS-CoV#

221篇内容 | 3607人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1937913, encodeId=cc83193e9132e, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Nature: 基于CRISPR的SARS-CoV-2快速诊断技术, objectType=article, longId=192454, objectId=747319245442, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=747319245442, replyNumber=0, likeNumber=54, createdTime=2020-10-22, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=747319245442, moduleTitle=Nature: 基于CRISPR的SARS-CoV-2快速诊断技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=747319245442)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937958, encodeId=eb82193e958d7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Gastroenterology：香港人群粪便样本中SARS-CoV-2感染的胃肠道表现和病毒载量, objectType=article, longId=201336, objectId=d8902013363f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8902013363f, replyNumber=0, likeNumber=51, createdTime=2021-06-26, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8902013363f, moduleTitle=Gastroenterology：香港人群粪便样本中SARS-CoV-2感染的胃肠道表现和病毒载量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8902013363f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937967, encodeId=a464193e9674a, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=J Infect：COVID-19的过程中，呼吸道样本中的SARS-CoV-2病毒载量变化模式, objectType=article, longId=203120, objectId=e06a203120dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e06a203120dd, replyNumber=0, likeNumber=75, createdTime=2021-07-23, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e06a203120dd, moduleTitle=J Infect：COVID-19的过程中，呼吸道样本中的SARS-CoV-2病毒载量变化模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e06a203120dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937955, encodeId=bac0193e9553f, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JNNP：与SARS-CoV-2相关的颅内血管炎的免疫抑制：对COVID-19患者脑血管病的治疗意义, objectType=article, longId=200454, objectId=1d642004540e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d642004540e, replyNumber=0, likeNumber=70, createdTime=2021-03-02, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d642004540e, moduleTitle=JNNP：与SARS-CoV-2相关的颅内血管炎的免疫抑制：对COVID-19患者脑血管病的治疗意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d642004540e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937896, encodeId=a506193e8964b, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=BMJ：中国浙江省SARS-Cov-2感染者的临床特征, objectType=article, longId=188436, objectId=dace1884369a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dace1884369a, replyNumber=0, likeNumber=71, createdTime=2021-01-27, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dace1884369a, moduleTitle=BMJ：中国浙江省SARS-Cov-2感染者的临床特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dace1884369a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937919, encodeId=db3e193e9195c, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=日本研发出新型SARS-CoV-2抗体, objectType=article, longId=194053, objectId=eac0194053be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eac0194053be, replyNumber=0, likeNumber=51, createdTime=2020-06-02, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eac0194053be, moduleTitle=日本研发出新型SARS-CoV-2抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eac0194053be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937949, encodeId=46e0193e94968, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Nat BME:基于Cas13的SARS-CoV-2RNA检测方法的临床验证, objectType=article, longId=199959, objectId=0f4c1999594a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f4c1999594a, replyNumber=0, likeNumber=64, createdTime=2021-05-23, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f4c1999594a, moduleTitle=Nat BME:基于Cas13的SARS-CoV-2RNA检测方法的临床验证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f4c1999594a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937947, encodeId=26f8193e947f9, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=J Autoimmun：意大利东北部自身免疫性风湿病患者的SARS-CoV-2感染情况, objectType=article, longId=199318, objectId=1b7619931895, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b7619931895, replyNumber=0, likeNumber=65, createdTime=2020-08-13, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b7619931895, moduleTitle=J Autoimmun：意大利东北部自身免疫性风湿病患者的SARS-CoV-2感染情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b7619931895)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937914, encodeId=b474193e914d0, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=medRxiv：李兰娟团队，SARS-CoV-2出现可改变其致病性的突变，体外感染很大显示270倍差异, objectType=article, longId=192745, objectId=83ad192e45b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83ad192e45b7, replyNumber=0, likeNumber=77, createdTime=2021-03-20, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83ad192e45b7, moduleTitle=medRxiv：李兰娟团队，SARS-CoV-2出现可改变其致病性的突变，体外感染很大显示270倍差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83ad192e45b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937927, encodeId=0c67193e92729, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JCEM：预测SARS-CoV-2致死性的评分, objectType=article, longId=195124, objectId=fdf6195124ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdf6195124ad, replyNumber=0, likeNumber=52, createdTime=2021-04-14, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdf6195124ad, moduleTitle=JCEM：预测SARS-CoV-2致死性的评分, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdf6195124ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937948, encodeId=d287193e948cf, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=抗COVID-19候选药物Brilacidin具有抗SARS-CoV-2活性！即将进行临床试验, objectType=article, longId=199923, objectId=466b1999231b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=466b1999231b, replyNumber=0, likeNumber=92, createdTime=2021-01-16, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=466b1999231b, moduleTitle=抗COVID-19候选药物Brilacidin具有抗SARS-CoV-2活性！即将进行临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=466b1999231b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937931, encodeId=683f193e93130, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Science Immunol：COVID-19-急性呼吸窘迫综合征患者的SARS-CoV-2特异性T细胞的表型和动力学, objectType=article, longId=196682, objectId=82e919668267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82e919668267, replyNumber=0, likeNumber=107, createdTime=2020-12-03, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82e919668267, moduleTitle=Science Immunol：COVID-19-急性呼吸窘迫综合征患者的SARS-CoV-2特异性T细胞的表型和动力学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82e919668267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937923, encodeId=c205193e9232b, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=重磅！Moderna的mRNA疫苗可激发健康志愿者产生SARS-CoV-2抗体, objectType=article, longId=194442, objectId=298e1944429a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=298e1944429a, replyNumber=0, likeNumber=58, createdTime=2021-04-05, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=298e1944429a, moduleTitle=重磅！Moderna的mRNA疫苗可激发健康志愿者产生SARS-CoV-2抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=298e1944429a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937960, encodeId=7957193e96010, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=GSK和Vir Biotechnology将抗SARS-CoV-2单克隆抗体推荐到III期临床, objectType=article, longId=201817, objectId=ab3520181ee0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab3520181ee0, replyNumber=0, likeNumber=73, createdTime=2021-07-19, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab3520181ee0, moduleTitle=GSK和Vir Biotechnology将抗SARS-CoV-2单克隆抗体推荐到III期临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab3520181ee0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937925, encodeId=6f18193e92553, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=NATURE：我国多单位合作发表靶向SARS-CoV-2受体结合位点的人类中和抗体, objectType=article, longId=194819, objectId=fc0c1948196c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc0c1948196c, replyNumber=0, likeNumber=64, createdTime=2021-02-04, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc0c1948196c, moduleTitle=NATURE：我国多单位合作发表靶向SARS-CoV-2受体结合位点的人类中和抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc0c1948196c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937906, encodeId=0393193e90617, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Lancet：呼吸道样本SARS-CoV-2 检测转阴后，粪便样本可能长时间仍为阳性, objectType=article, longId=190581, objectId=39c9190581ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39c9190581ae, replyNumber=0, likeNumber=48, createdTime=2020-11-29, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39c9190581ae, moduleTitle=Lancet：呼吸道样本SARS-CoV-2 检测转阴后，粪便样本可能长时间仍为阳性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39c9190581ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937953, encodeId=f69d193e953ee, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Nature：小鼠SARS-CoV-2模型助力COVID-19疫苗开发, objectType=article, longId=200262, objectId=b440200262fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b440200262fd, replyNumber=0, likeNumber=67, createdTime=2020-12-09, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b440200262fd, moduleTitle=Nature：小鼠SARS-CoV-2模型助力COVID-19疫苗开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b440200262fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937922, encodeId=f521193e9223f, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=CELL：我国研究人员从患者中鉴定出抗SARS-CoV-2的潜在中和抗体 , objectType=article, longId=194360, objectId=1bca19436045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bca19436045, replyNumber=0, likeNumber=61, createdTime=2021-04-22, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bca19436045, moduleTitle=CELL：我国研究人员从患者中鉴定出抗SARS-CoV-2的潜在中和抗体 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bca19436045)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937932, encodeId=f9f4193e93296, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=阻止SARS-CoV-2复制的潜在药物：boceprevir和GC-376, objectType=article, longId=197178, objectId=71b519e17889, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71b519e17889, replyNumber=0, likeNumber=67, createdTime=2020-12-15, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71b519e17889, moduleTitle=阻止SARS-CoV-2复制的潜在药物：boceprevir和GC-376, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71b519e17889)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937894, encodeId=4f83193e89470, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=新型冠状病毒正式被命名为SARS-COV-2病毒, objectType=article, longId=187921, objectId=8e2318e921f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e2318e921f6, replyNumber=0, likeNumber=61, createdTime=2020-09-04, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e2318e921f6, moduleTitle=新型冠状病毒正式被命名为SARS-COV-2病毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e2318e921f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SARS-CoV

2020-05-29

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Nature: 基于CRISPR的SARS-CoV-2快速诊断技术

2020-10-22

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Gastroenterology：香港人群粪便样本中SARS-CoV-2感染的胃肠道表现和病毒载量

2021-06-26

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

J Infect：COVID-19的过程中，呼吸道样本中的SARS-CoV-2病毒载量变化模式

2021-07-23

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JNNP：与SARS-CoV-2相关的颅内血管炎的免疫抑制：对COVID-19患者脑血管病的治疗意义

2021-03-02

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

BMJ：中国浙江省SARS-Cov-2感染者的临床特征

2021-01-27

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

日本研发出新型SARS-CoV-2抗体

2020-06-02

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Nat BME:基于Cas13的SARS-CoV-2RNA检测方法的临床验证

2021-05-23

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

J Autoimmun：意大利东北部自身免疫性风湿病患者的SARS-CoV-2感染情况

2020-08-13

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

medRxiv：李兰娟团队，SARS-CoV-2出现可改变其致病性的突变，体外感染很大显示270倍差异

2021-03-20

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JCEM：预测SARS-CoV-2致死性的评分

2021-04-14

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

抗COVID-19候选药物Brilacidin具有抗SARS-CoV-2活性！即将进行临床试验

2021-01-16

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Science Immunol：COVID-19-急性呼吸窘迫综合征患者的SARS-CoV-2特异性T细胞的表型和动力学

2020-12-03

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

重磅！Moderna的mRNA疫苗可激发健康志愿者产生SARS-CoV-2抗体

2021-04-05

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

GSK和Vir Biotechnology将抗SARS-CoV-2单克隆抗体推荐到III期临床

2021-07-19

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

NATURE：我国多单位合作发表靶向SARS-CoV-2受体结合位点的人类中和抗体

2021-02-04

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Lancet：呼吸道样本SARS-CoV-2 检测转阴后，粪便样本可能长时间仍为阳性

2020-11-29

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Nature：小鼠SARS-CoV-2模型助力COVID-19疫苗开发

2020-12-09

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

CELL：我国研究人员从患者中鉴定出抗SARS-CoV-2的潜在中和抗体

2021-04-22

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

阻止SARS-CoV-2复制的潜在药物：boceprevir和GC-376

2020-12-15

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

新型冠状病毒正式被命名为SARS-COV-2病毒

2020-09-04

科室
- - 订阅+
  - 更多科室
工具
服务